← Who reports today · Health Care
STE · Q1 FY2027
Archived report (Q1 FY2027). Latest deep dive →
The quarter in brief
Revenue grew 7.3% y/y to $1.49B, operating margin 19.1% vs 17.7%, net income $200M (+12.8% y/y).
Net income attributable to shareholders
$200M
up 12.8% y/y
Revenues
$1,493M
up 7.3% y/y
Income from operations
$286M
up 16.2% y/y
Gross profit
$684M
up 8.9% y/y
All figures in $M.
| Line item | Amount and change |
|---|---|
| Revenues | $1,493 · +7.3% |
| Cost of revenues | $809 · +6.0% |
| Gross profit | $684 · +8.9% · 45.8% margin |
| Selling, general, and administrative | $370 · +4.5% |
| Research and development | $28.6 · +8.3% |
| Income from operations | $286 · +16.2% · 19.1% margin |
| Interest expense | $15.8 · −0.6% |
| Interest and miscellaneous income | $3.1 · +72.2% |
| Other income, net | $0.3 · vs $0 |
| Income before income tax expense | $274 · +17.9% |
| Income tax expense | $72.5 · +34.5% · 26.5% effective rate |
| Less: Net income attributable to noncontrolling interests | $0.9 · +50.0% |
| Net income attributable to shareholders | $200 · +12.8% · $2.04/sh · 13.4% margin |
Verdict: revenue grew 7.3% y/y to $1.49B, operating margin 19.1% vs 17.7%, net income $200M (+12.8% y/y).
Adjusted net income was $253.4 million, or $2.59 per diluted share.
Source and notation
Source: STERIS press release, 8-K EX-99.1 of 08/05/2026 (SEC EDGAR). Every figure was matched against the income statement in the release and checked against SEC XBRL.
Open as an image: STE, Q1 FY2027 (PNG) ↗ · for sharing and presentations · free to reuse, CC BY 4.0
Cite / embed this chart
Free to use in articles, research and social posts with credit to Who Reports Today and a link — licensed under CC BY 4.0 (terms).
Chart: “STE Q1 FY2027: where the revenue went” by Who Reports Today, https://whoreportstoday.com/t/ste/q1-fy2027. Licensed under CC BY 4.0.
<figure> <a href="https://whoreportstoday.com/t/ste/q1-fy2027"><img src="https://whoreportstoday.com/t/ste/q1-fy2027/sankey.png" alt="STE Q1 FY2027: where the revenue went" loading="lazy" style="max-width:100%;height:auto"></a> <figcaption>Source: <a href="https://whoreportstoday.com/t/ste/q1-fy2027">Who Reports Today</a>, licensed under <a href="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0</a></figcaption> </figure>
https://whoreportstoday.com/t/ste/q1-fy2027/sankey.png
<a href="https://whoreportstoday.com/t/ste/q1-fy2027">STE Q1 FY2027 earnings chart (Who Reports Today)</a>
This is an archived report: the image at this link won’t change. If you change the chart (crop, translate), say so in the credit. Company logos and trademarks are not covered by the license.
- Healthcare revenue grew 8% to $1.05 billion, and Applied Sterilization Technologies revenue rose 6% to $297.6 million.
- Gross margin was 45.8% vs 45.1% a year earlier.
- Operating income was $286M, a 19.1% margin vs 17.7% a year earlier.
- The effective tax rate was 26.5% vs 23.2% a year earlier.
- Diluted EPS was $2.04 vs $1.79 a year earlier.
What distorts the picture in this report and what to watch beyond the headlines.
STE — an Irish-incorporated provider of infection prevention products and services for hospitals, medical device makers and pharmaceutical companies.
It sells consumables, sterilizers, surgical tables and endoscope reprocessors and offers maintenance, repair and outsourced sterilization services. It earns money in three segments: Healthcare, Applied Sterilization Technologies and Life Sciences. · Source: annual report (Form 10-K, SEC)
More reports: SYK · Q3 2026 · TECH · Q4 FY2026 · TMO · Q3 2026 · UHS · Q3 2026 · UNH · Q3 2026 · VEEV · Q2 FY2027 · VRTX · Q3 2026 · VTRS · Q2 2026 · WAT · Q3 2026 · WST · Q3 2026 · all reports